03 Mistletoe information

Permanent URI for this collection

https://hdl.handle.net/20.500.14430/4

Mistletoe is the English common name for over 1200 species of a semi-parasitic plant that grows on trees worldwide, though only viscum album (European or common mistletoe) is used in the treatment of cancer and inflammatory conditions. References to mistletoe as a sacred plant and remedy appear throughout history and date as far back as the writings of Hippocrates (c. 460 - c. 370) and Pliny the Elder (AD 23-79), but it was only through the indications of Rudolf Steiner, in the early 1920's, that it became known that mistletoe could be used for the treatment of cancer. It was then developed as an injection.

Since that time, European oncologists have been using the liquid extract of the mistletoe plant with the goal to improve survival in patients with cancer and to improve quality of life by reducing the side-effects of chemotherapy and radiation, such as nausea, vomiting and lack of appetite, as well as diminishing tumor-related pain. Mistletoe injections are currently among the most widely used complementary cancer treatments in Europe. It is approved for palliative care use in several European countries, but not yet in the United States. Until further clinical testing is done in the US, oncologists cannot offer this treatment as standard of care for cancer patients. Mistletoe is being administered in the US by complementary medicine practitioners, but mistletoe is not approved by the FDA for cancer treatment.

The clinical effectiveness of mistletoe extracts in cancer has been investigated in a great number of studies and clinical trials, primarily in Europe. A clinical trial is currently being conducted in the US at Johns Hopkins School of Medicine.

Browse

Browsing 03 Mistletoe information by Author

None of the information provided on Mistletoe should be interpreted as an endorsement or position of PAAM to use Mistletoe in the clinical setting. These materials are for research and educational purposes only. Mistletoe is not FDA approved for treatment of cancer or any disease. It is the sole responsibility of clinicians to offer this supplement in their practice. PAAM does not recommend mistletoe as a replacement for treatments prescribed by trained and board certified oncologists. Only licensed clinicians can prescribe mistletoe. They should be fully trained in its adjuvant or supplemental use and potential side effects, drug interactions, contraindications and appropriate indications.